Related Experiment Videos
Pneumocystis jirovecii multilocus gene sequencing: findings and implications
Olga Matos1, Francisco Esteves
1Unidade de Protozoários Oportunistas/VIH e Outras Protozooses, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal. omatos@ihmt.unl.pt
Abstract:
Pneumocystis jirovecii pneumonia (PcP) remains a major cause of respiratory illness among immunocompromised patients, especially patients infected with HIV, but it has also been isolated from immunocompetent persons. This article discusses the application of multilocus genotyping analysis to the study of the genetic diversity of P. jirovecii and its epidemiological and clinical parameters, and the important concepts achieved to date with these approaches. The multilocus typing studies performed until now have shown that there is an important genetic diversity of stable and ubiquitous P. jirovecii genotypes; infection with P. jirovecii is not necessarily clonal, recombination between some P. jirovecii multilocus genotypes has been suggested. P. jirovecii-specific multilocus genotypes can be associated with severity of PcP. Patients infected with P. jirovecii, regardless of the form of infection they present with, are part of a common human reservoir for future infections. The CYB, DHFR, DHPS, mtLSU rRNA, SOD and the ITS loci are suitable genetic targets to be used in further epidemiological studies focused on the identification and characterization of P. jirovecii haplotypes correlated with drug resistance and PcP outcome.
Insights
Multilocus genotyping reveals genetic diversity in Pneumocystis jirovecii, suggesting recombination and genotypes linked to Pneumocystis pneumonia severity. This aids understanding of PcP epidemiology and patient outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Molecular Epidemiology
Background:
- Pneumocystis jirovecii pneumonia (PcP) is a significant respiratory illness in immunocompromised individuals, particularly those with HIV.
- P. jirovecii has also been identified in immunocompetent individuals, indicating a broader host range.
- Understanding the genetic diversity of P. jirovecii is crucial for its epidemiology and clinical impact.
Purpose of the Study:
- To review the application of multilocus genotyping in studying P. jirovecii genetic diversity.
- To discuss epidemiological and clinical parameters associated with P. jirovecii genotypes.
- To highlight key findings from multilocus typing studies.
Main Methods:
- Multilocus genotyping analysis of P. jirovecii.
- Analysis of genetic diversity, epidemiological data, and clinical parameters.
- Review of existing multilocus typing studies.
Main Results:
- Multilocus typing reveals significant genetic diversity of P. jirovecii, with stable and ubiquitous genotypes.
- P. jirovecii infections are not strictly clonal, and recombination between genotypes is suggested.
- Specific P. jirovecii multilocus genotypes may correlate with PcP severity.
Conclusions:
- P. jirovecii infections contribute to a common human reservoir.
- Genetic characterization of P. jirovecii is essential for understanding drug resistance and PcP outcomes.
- Suitable genetic targets (CYB, DHFR, DHPS, mtLSU rRNA, SOD, ITS) are identified for future epidemiological studies.
Related Concept Videos
Pneumonia II: Pathophysiology
Modern Molecular Taxonomy
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Single Nucleotide Polymorphisms-SNPs
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...